Last reviewed · How we verify
NCT04948996
Treatment of Depression Using a Mobile Application in the Dominican Republic
NA trial testing El Buen Consejo Móvil- Group (EBCM-G) in Depression Mild in 27 participants. Terminated before completion.
31 December 2021
Quick facts
| Lead sponsor | Northern Illinois University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 27 |
| Start date | 30 January 2021 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 2 locations across United States, Dominican Republic |
Drugs / interventions tested
- El Buen Consejo Móvil- Group (EBCM-G)
- El Buen Consejo Móvil- Individual (EBCM-I)
Conditions studied
- Depression Mild — all drugs for Depression Mild →
- Depression Moderate — all drugs for Depression Moderate →
Sponsor
Northern Illinois University
Who can join
Adults 18 to 110, any sex, with Depression Mild or Depression Moderate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective of this study is to develop a feasible and acceptable mental health app which delivers Cognitive Behavioral Therapy (CBT) for depressed patients in the Dominican Republic. This proposal meets the research objectives of NIMH in delivering mental health care to populations with low literacy, and supporting health care systems in monitoring and improving the quality of mental health. In the proposed study, the investigators will upgrade, implement, and evaluate a depression treatment app and assess trained facilitators' capacity in managing participants' depression symptoms using the app. The investigators will conduct a randomized controlled trial (RCT) among 120 participants who screen positive for mild to moderate depression or anxiety on the Patient Health Questionnaire (PHQ-9) or GAD- 7 via a university-based Covid mental health hotline. The app, El Buen Consejo Móvil (EBCM), will be downloaded to the participants' own Android phone. Participants will be randomized to receive the EBCM app with the functionality to connect individuals to one another via a facilitator-guided chat room (ECBM-G; n= 60) or to receive the same contents as an individualized facilitator-guided CBT program without the group functionality (ECBM-I; n=60). Recruitment and mixed-methods data collection will be conducted by phone, given current circumstances surrounding the Covid-19 pandemic. Process outcomes will be evaluated for the trained facilitators. The primary outcomes for app users will be acceptability of the app and perceptions of social interactivity for those randomized to the group condition. Validated questionnaires will be administered to measure perceived emotional support, loneliness, and interactivity. Level of adherence and effectiveness, the secondary outcomes, will be assessed by frequency of interaction with the app, completion of treatment for either treatment modality, and change in depressive symptoms. The investigators hypothesize that the use of the app for guided self-help can be enhanced through group interaction. EBCM can result in increased access to care in low-income community settings where patients are not currently receiving treatment due to logistical barriers and the stigma of seeking care in a mental health care setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04948996
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression Mild
Currently open trials in the same condition.
- NCT06735885 — fMRI Neurofeedback With Matter Neuroscience App · NA · recruiting
- NCT06456931 — A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based Cogni · NA · recruiting
- NCT06374056 — Kintsugi Voice Device Pilot Study · active not recruiting
- NCT06273995 — Telehealth Behavioral Activation for Teens · NA · recruiting
- NCT05788198 — Integrated Depression Care · NA · recruiting
Other Northern Illinois University trials
Trials by the same sponsor.
- NCT07397273 — Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance. · NA · not yet recruiting
- NCT07217210 — Multi-Ingredient Preworkout Supplement on Peak Torque and Muscle Activation During Fatigue · NA · completed
- NCT04080115 — Does Increasing Attentional Control Decrease Acute Fear Response · NA · completed
- NCT04539054 — Pre-workout Supplement Versus Caffeine on Energy Expenditure. · NA · completed
- NCT03804047 — KITAMS: Kinesio Tape and Physical Function in Persons With Multiples Sclerosis · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04948996 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northern Illinois University
- Last refreshed: 8 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04948996.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing